Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opatin + 5-FU in Recurrent/Metastatic Head and Neck Cancer
NCT01370876Phase 2Terminated
- Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olopatadine in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Nang Kuang Pharmaceutical Co., Ltd.. Started Sep 2010; status: terminated.
02
Drugs
olopatadine
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01370876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370876.